Study in Patients With Asthma
NCT00215410 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 36
Last updated 2010-11-11
Summary
The purpose of this study is to determine the most safe and effective dose of the investigational drug in comparison with a control drug and placebo.
Conditions
Interventions
- DRUG
-
Formoterol Fumarate
Sponsors & Collaborators
-
Dey
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 5 Years
- Max Age
- 12 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Primary Completion
- 2003-10-31
- Completion
- 2005-10-31
Countries
- United States
Study Locations
More Related Trials
-
A 12-Week Study in Adult Subjects With Asthma
NCT01516086 ·Status: COMPLETED ·Phase: PHASE2
-
New Combination Inhaler (FlutiForm HFA MDI 100/10 µg and 250/10 µg) in Patients With Asthma
NCT00394121 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of a Pharmaceutical Intervention on the Level of Control of the Asthmatic Patient
NCT01085474 ·Status: COMPLETED
-
A 3-week Study Investigating Patient Use and Functionality of Formoterol in a Novel Inhalation Device in Patients With Asthma
NCT00130351 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Inhaled Mometasone/Formoterol Versus Inhaled Fluticasone/Salmeterol in Asthma Patients
NCT02415179 ·Status: COMPLETED ·Phase: NA
-
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate in People With Asthma
NCT01436071 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of New Combination Inhaler (FlutiForm HFA MDI 100/10 µg) Versus Fluticasone and Formoterol Administered Alone, and Placebo, in Patients With Asthma
NCT00393991 ·Status: COMPLETED ·Phase: PHASE3
-
A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH)
NCT03086460 ·Status: COMPLETED ·Phase: PHASE2
-
A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma
NCT01591044 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety Study to Compare Formoterol Fumerate in the Pressair DPI to the Foradil Aerolizer in Patient With Mild to Moderate Asthma
NCT01641081 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Roflumilast in Patients With Asthma (BY217/M2-012)
NCT00073177 ·Status: COMPLETED ·Phase: PHASE3
-
Investigation Of A New Medication (GW642444) In Asthmatic Patients
NCT00354874 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Assess Bronchospasm Potentially Induced by Next-Generation Propellant vs HFA Propellant in an MDI in Participants With Well/Partially Controlled Asthma
NCT05850494 ·Status: COMPLETED ·Phase: PHASE3
-
12-Week Study in Adult Subjects With Asthma
NCT01516073 ·Status: COMPLETED ·Phase: PHASE2
-
As-needed Budesonide/Formoterol Turbuhaler in Stepping Down Period
NCT04215848 ·Status: COMPLETED ·Phase: PHASE3
-
Flutiform in Treatment of Patients With Asthma in Daily Clinical Practice.
NCT02811315 ·Status: WITHDRAWN
-
The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)
NCT00076076 ·Status: COMPLETED ·Phase: PHASE3
-
Repeat Dose Safety Study for Compound to Treat Asthma
NCT01202214 ·Status: COMPLETED ·Phase: PHASE1
-
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
NCT01225913 ·Status: RECRUITING ·Phase: PHASE4
-
Study With GW274150 In Patients With Mild Asthma
NCT00273013 ·Status: COMPLETED ·Phase: PHASE1
-
Asthma Comparative Effectiveness Study
NCT01623544 ·Status: COMPLETED
-
Single Dose Study of GSK1440115 in Patients With Asthma
NCT01424280 ·Status: COMPLETED ·Phase: PHASE1
-
Investigation of Efficacy, Safety and Tolerability of Once and Twice Daily Doses of AZD1981 in Asthmatic Patients
NCT01197794 ·Status: COMPLETED ·Phase: PHASE2
-
Fluticasone Furoate/GW642444 Inhalation Powder Long-Term Safety Study
NCT01018186 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
NCT06977581 ·Status: RECRUITING ·Phase: PHASE2